Singapore's healthcare system is taking a giant leap forward in the battle against sarcoma, a rare and complex cancer that disproportionately affects adolescents and young adults. The National University Cancer Institute, Singapore (NCIS), is leading a multidisciplinary effort to transform sarcoma diagnosis and care, with far-reaching implications for patients across the region.
A Rare Cancer with Complex Needs
Sarcoma, a group of bone and soft tissue cancers, presents unique challenges due to its rarity and complexity. With over 100 subtypes, each requiring different diagnostic and treatment pathways, effective sarcoma care heavily relies on specialised expertise and coordinated multidisciplinary management. Mr. Terence Goh's experience highlights this complexity. Diagnosed with retroperitoneal pleomorphic sarcoma in 2023, his treatment journey involved neoadjuvant radiotherapy, complex surgeries, and a multidisciplinary approach, showcasing the intricate nature of sarcoma care.
Early Identification and Referral: The Key Challenges
One of the primary hurdles in sarcoma care is early identification. Many clinicians encounter sarcoma infrequently, leading to uncertainty in recognising suspicious features and deciding when to escalate care. Adjunct Professor Mark Edward Puhaindran emphasises the importance of strengthening awareness and mapping out clearer decision pathways to improve outcomes. This is especially crucial given that sarcoma accounts for approximately 21% of paediatric cancers, affecting many adolescents and young adults.
Developing Expert Multidisciplinary Guidance
To address these challenges, clinicians from Singapore and international centres have collaborated to develop expert multidisciplinary guidance. The creation of the 'Clinical Management of Bone and Soft Tissue Tumours' handbook is a significant milestone. This comprehensive resource, led by Associate Professor Victor Lee Kwan Min and Associate Professor James Hallinan, brings together the collective expertise of 70 local and international contributors. It aims to support healthcare professionals in navigating complex diagnostic pathways, identifying when specialist referral is required, and determining appropriate multimodal treatment approaches.
Beyond Diagnosis: Fighting Cancer with Purpose
The impact of this initiative extends beyond diagnosis. Mr. Hilman Basri's story exemplifies the transformative power of multidisciplinary care. Initially dismissed as a minor issue, his clear cell sarcoma diagnosis led to complex surgeries and ongoing medical treatment. Under the care of Adjunct Professor Puhaindran, Mr. Basri's management included long-term follow-up, rehabilitation, and a healthier lifestyle. His annual participation in the Run For Hope Marathon demonstrates resilience and a positive outlook, turning cancer into a catalyst for personal growth and community support.
Looking Ahead
Singapore's approach to sarcoma care is a testament to the power of collaboration and specialised expertise. By strengthening early identification, developing comprehensive clinical guidance, and fostering multidisciplinary collaboration, the country is poised to significantly improve outcomes for sarcoma patients. This initiative not only benefits Singapore but also has the potential to set a global standard for sarcoma care, offering hope and better outcomes for patients worldwide.
